Fox News reports semaglutide and tirzepatide may help joints, inflammation and organs ahead of any weight change, per the research it cites.
Recap by typeshit. Full story at Fox News on MSN.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Engel, 63, lost sight in both eyes to NAION and says he was never warned. Hundreds of similar suits are pending, though a causal link hasn't been proven.
Medscape reviews side effects Reddit users say they have had on retatrutide, a Lilly drug that is still in trials and not approved.
Loading…